Concepedia

Scott M. Doran

SM

Statistics

Publications

24

Citations

3.4K

H-Index

23

Active since

1999

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Merck Biopharma Co., Ltd. (Japan)

Institute of Medicinal Plant Development

Amgen (United States)

Scott M. Doran is an author at United States Military Academy specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1999–2012

24

Publications

24

Sustained attention performance during sleep deprivation: evidence of state instability.

Scott M. Doran, Hans P. A. Van Dongen, David F. Dinges · PubMed · 2001 · 808 citations

, , +16

Discovery of the Dual Orexin Receptor Antagonist [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia

Christopher D. Cox, Michael J. Breslin, David B. Whitman et al. · Journal of Medicinal Chemistry · 2010 · 370 citations · Full text

, , +12

EEG coherency II: experimental comparisons of multiple measures

Paul L. Nunez, Richard B. Silberstein, Zhiping Shi et al. · Clinical Neurophysiology · 1999 · 322 citations

, , +13

Selective activation of the M <sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation

Lei Ma, Matthew A. Seager, Marion Wittmann et al. · Proceedings of the National Academy of Sciences · 2009 · 284 citations · Full text

, , +17

Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist

Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox et al. · Journal of Neurogenetics · 2011 · 270 citations

, , +16

1–5 of 24